Tarsadia Strengthens Venture, Growth & Private Investing Practice with New Sector Heads
Gracie Gottlieb | 19 September, 2023
Tarsadia Investments, a renowned multibillion-dollar private investment management vehicle, is taking its Venture, Growth & Private Investing (VGP) practice to new heights with the addition of two industry experts. This strategic move reinforces Tarsadia's commitment to driving transformative change in the financial technology, software, and healthcare sectors.
With a permanent capital base, Tarsadia offers entrepreneurs maximum alignment by partnering with them over a decade-plus investment horizon. The company combines deep thematic research with decades of operating experience to make high-conviction investments across various stages. Tarsadia's multi-disciplinary and collaborative approach across venture, private equity, and public markets provides unique insight and support for founders throughout their business life cycle. Moreover, the firm's flexible mandate enables creative deal structures, including financing growth, recapitalizations, or acquisitions of significant competitors.
Rikhil Bajaj has been appointed as the head of VGP investments in financial technology, software, and digital assets. With a wealth of experience working with growth-stage businesses, Rikhil brings expertise in growth strategies, talent acquisition, and financing/M&A. Prior to joining Tarsadia, Rikhil served as a founding member of the growth equity team at SignalFire, a renowned $1.5 billion venture fund. He was also part of the senior team at GTCR, a prestigious $20 billion private equity firm. Rikhil's investment background extends to technology and healthcare, having worked at firms like Warburg Pincus and Primus Capital. He holds an MBA from The Wharton School at the University of Pennsylvania and a BBA (Honors) from the Schulich School of Business, York University.
Dr. Shubhra Jain will be leading the VGP investments in healthcare technology, leveraging her extensive experience as a physician and her tech acumen. Dr. Jain's objective is to support founders in building a more equitable, affordable, and effective healthcare ecosystem. Before joining Tarsadia, she successfully built and led a healthcare investment practice at Cota Capital. Dr. Jain's portfolio includes investments in prominent businesses like Berkeley Lights, Zymergen, and Mission Bio. In addition to her investment expertise, she also has operating experience leading product development and launch at a health-tech startup. Dr. Jain is a primary care physician by background and holds an M.S. in Engineering from Stanford School of Engineering and an MBA from The Wharton School.
"We are constantly evolving and elevating our team to augment our founder-first DNA," said Rishi Reddy, Managing Director and Head of the VGP practice at Tarsadia Investments. "We are excited to welcome Rikhil Bajaj and Dr. Shubhra Jain to our team. Their investment experience and sector expertise will play a crucial role in our mission to support visionary founders and drive transformative change in these industries."
Tarsadia Investments, LLC, is a private investment management vehicle with a multibillion-dollar portfolio. The company focuses on making high-conviction investments in category-defining companies across the globe. With a supportive and value-enhancing approach, Tarsadia seeks out exceptional management teams and invests across various stages, from idea to public ownership. The firm utilizes its domain expertise in financial services, healthcare, real estate, and technology to support founders in areas such as growth strategies, talent acquisition, and M&A/capital raising.
In conclusion, Tarsadia's decision to strengthen its Venture, Growth & Private Investing practice with the addition of two sector heads showcases its commitment to driving positive change in the financial technology, software, and healthcare industries. Rikhil Bajaj and Dr. Shubhra Jain bring their expertise and investment experience, which will undoubtedly contribute to Tarsadia's mission of supporting visionary founders and catalyzing transformative change in these sectors. As Tarsadia continues to evolve and enhance its team, its founder-first approach remains at the core of its strategy, ensuring long-term success for both the firm and its portfolio companies.
Other Posts
- Marble Harbor Investment Counsel Q4 2022 vs. Q1 2023 13F Holdings
- SignalPoint Asset Management, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Understanding the Investment Shifts: A Deep Dive Into Kovack Advisors' Recent Moves
- Top Changes in Holdings of Soma Equity Partners LP Q3 2022 vs. Q4 2022
- Honeycomb Asset Management LP Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Navigating Trends: A Comprehensive Analysis of Q4 2023 to Q1 2024 Fund Holdings Shifts
- Tracking the Q3-Q4 2022 Holdings Comparison of Morningstar Investment Management LLC
- Independent Investors Inc Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Analyzing Changes in Holdings for Cullinan Associates Inc. Fund in Q1 2023: Notable Shifts and Interesting Trends
- Aft, Forsyth & Company, Inc. Q4 2022 vs. Q1 2023 - A Detailed Look at the Biggest Fund Holdings